0GC0.F
Ridgeline Minerals Corp.
FrankfurtEUREQUITY
Basic Materials
DELAYED
Last price
0.15
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.15
Day high
0.15
Day low
0.15
Volume
2.00K
Market cap
$21.63M
P/E (TTM)
15.00
52W range
0.09 – 0.20
Trailing performance
Returnvs SPY
1W
+1.35%
+2.7%
1M
+57.89%
+54.2%
3M
+45.63%
+42.5%
6M
+20.97%
+9.9%
YTD
-22.28%
-34.6%
1Y
+70.45%
+50.5%
3Y
+21.95%
-52.2%
5Y
-48.28%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0GC0.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.50M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 20, 25 | Harp (Michael) Senior Officer of Issuer |
— | 16.67K | — | Direct |
| Sep 12, 25 | Gieselman Terese Senior Officer of Issuer |
— | 25.00K | — | Direct |
| Sep 12, 25 | Harp (Michael) Senior Officer of Issuer |
— | 58.33K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Gieselman Terese |
Senior Officer of Issuer | 50.00K | Exercise of rights |
Harp (Michael) |
Senior Officer of Issuer | 550.33K | Exercise of rights |
Fundamentals
Market cap$21.63M
Enterprise value$18.68M
Revenue (TTM)—
Gross profit—
EBITDA$-1.07M
Net income$181.76K
EPS (TTM)$0.01
Free cash flow$-2.93M
Total cash$3.06M
Total debt$106.23K
Book value / share$0.10
Shares outstanding144.20M
Float138.11M
Short % of float—
Dividend yield—
Beta (5Y)0.99
Valuation & profitability ratios
Trailing P/E15.00
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.44
EV / revenue—
EV / EBITDA-17.51
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity1.15%
Return on assets-4.33%
Debt / equity0.61
Current ratio22.30
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Cost of revenue | $87.76K | $81.16K | $56.20K | $79.42K | +8.1% |
| Gross profit | -$87.76K | -$81.16K | -$56.20K | -$79.42K | -8.1% |
| Selling, general & admin | $1.42M | $1.19M | $845.48K | $937.47K | +19.9% |
| Total operating expense | $1.42M | $1.19M | $845.48K | $937.47K | +19.9% |
| Operating income | -$1.51M | -$1.27M | -$901.68K | -$1.02M | -19.2% |
| Net interest income | $31.27K | $14.39K | $39.08K | $22.28K | +117.3% |
| Pre-tax income | $261.18K | -$1.05M | -$903.68K | -$970.25K | +124.9% |
| Tax provision | $170.06K | $0 | — | — | — |
| Net income | $91.13K | -$1.05M | -$903.68K | -$970.25K | +108.7% |
| Net income to common | $91.13K | -$1.05M | -$903.68K | -$970.25K | +108.7% |
| Basic EPS | 0.01 | -0.01 | -0.01 | -0.02 | +200.0% |
| Diluted EPS | 0.01 | -0.01 | -0.01 | -0.02 | +200.0% |
| EBIT | -$1.51M | -$1.27M | -$901.68K | -$1.02M | -19.2% |
| EBITDA | -$1.42M | -$1.19M | -$845.48K | -$937.47K | -19.9% |
| Basic shares | 136.00M | 103.21M | 83.91M | 58.98M | +31.8% |
| Diluted shares | 136.00M | 103.21M | 83.91M | 58.98M | +31.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $752.22K | $602.91K | $505.05K | $1.19M | +24.8% |
| Cash & short-term investments | $2.72M | $702.91K | $505.05K | $1.19M | +286.8% |
| Accounts receivable | $769.90K | $13.00K | $16.21K | $17.14K | +5,822.3% |
| Total current assets | $3.53M | $827.48K | $682.42K | $1.32M | +327.1% |
| Property, plant & equipment | $13.84M | $10.95M | $11.01M | $8.43M | +26.4% |
| Total assets | $17.52M | $11.99M | $11.70M | $9.75M | +46.0% |
| Total current liabilities | $636.26K | $508.90K | $118.92K | $706.60K | +25.0% |
| Current debt | $34.10K | $34.10K | $19.48K | $19.48K | 0.0% |
| Long-term debt | $71.59K | $103.44K | $41.08K | $59.77K | -30.8% |
| Total debt | $121.13K | $177.10K | $116.12K | $84.88K | -31.6% |
| Total liabilities | $799.85K | $623.35K | $195.15K | $766.38K | +28.3% |
| Retained earnings | -$5.59M | -$5.68M | -$4.63M | -$3.73M | +1.6% |
| Shareholder equity | $16.72M | $11.37M | $11.50M | $8.98M | +47.0% |
| Working capital | $2.90M | $318.58K | $563.50K | $609.96K | +809.6% |
| Net tangible assets | $16.72M | $11.37M | $11.50M | $8.98M | +47.0% |
| Shares issued | 141.28M | 109.73M | 91.20M | 68.55M | +28.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $91.13K | -$1.05M | -$903.68K | -$970.25K | +108.7% |
| Depreciation & amortisation | $87.76K | $81.16K | $56.20K | $79.42K | +8.1% |
| Stock-based compensation | $373.32K | $338.38K | $17.00K | $170.08K | +10.3% |
| Change in working capital | -$150.29K | $416.37K | -$17.59K | -$22.93K | -136.1% |
| Operating cash flow | -$649.24K | -$601.34K | -$794.87K | -$674.05K | -8.0% |
| Capital expenditure | -$2.58M | -$835.06K | -$2.95M | -$1.77M | -208.5% |
| Investing cash flow | -$2.58M | -$785.06K | -$2.95M | -$1.77M | -228.1% |
| Financing cash flow | $3.32M | $1.50M | $3.06M | $1.77M | +121.2% |
| Free cash flow | -$3.23M | -$1.44M | -$3.75M | -$2.44M | -124.5% |
| End cash position | $752.22K | $602.91K | $505.05K | $1.19M | +24.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Cost of revenue | $20.05K | $20.24K | $22.60K | $22.60K | $22.32K | -1.0% |
| Gross profit | -$20.05K | -$20.24K | -$22.60K | -$22.60K | -$22.32K | +1.0% |
| Selling, general & admin | $271.75K | $214.58K | $637.12K | $289.90K | $282.15K | +26.6% |
| Total operating expense | $271.75K | $214.58K | $637.12K | $289.90K | $282.15K | +26.6% |
| Operating income | -$291.80K | -$234.82K | -$659.72K | -$312.50K | -$304.48K | -24.3% |
| Net interest income | $898 | $2.21K | $10.75K | $9.84K | $8.47K | -59.4% |
| Pre-tax income | -$179.49K | -$203.21K | $1.05M | -$316.92K | -$270.12K | +11.7% |
| Net income | -$179.49K | -$373.27K | $1.05M | -$316.92K | -$270.12K | +51.9% |
| Net income to common | -$179.49K | -$373.27K | $1.05M | -$316.92K | -$270.12K | +51.9% |
| Basic EPS | 0.00 | — | 0.01 | 0.00 | 0.00 | — |
| Diluted EPS | 0.00 | — | 0.01 | 0.00 | 0.00 | — |
| EBIT | -$291.80K | -$234.82K | -$659.72K | -$312.50K | -$304.48K | -24.3% |
| EBITDA | -$271.75K | -$214.58K | -$637.12K | -$289.90K | -$282.15K | -26.6% |
| Basic shares | 143.68M | — | 139.74M | 139.53M | 124.06M | — |
| Diluted shares | 143.68M | — | 139.74M | 139.53M | 124.06M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $500.52K | $752.22K | $1.21M | $1.25M | $2.59M | — | -33.5% |
| Cash & short-term investments | $3.06M | $2.72M | $3.37M | $1.35M | $2.69M | — | +12.4% |
| Accounts receivable | $940.20K | $769.90K | $16.71K | $13.14K | $17.68K | — | +22.1% |
| Total current assets | $4.03M | $3.53M | $3.60M | $1.50M | $3.16M | — | +13.9% |
| Property, plant & equipment | $13.59M | $13.84M | $13.19M | $13.82M | $11.70M | — | -1.8% |
| Total assets | $17.76M | $17.52M | $16.79M | $15.32M | $14.86M | — | +1.4% |
| Total current liabilities | $180.51K | $636.26K | $834.74K | $465.90K | $487.25K | — | -71.6% |
| Current debt | $34.10K | $34.10K | — | $34.10K | $34.10K | $34.10K | 0.0% |
| Long-term debt | $63.24K | $71.59K | $79.76K | $87.75K | $95.68K | — | -11.7% |
| Total debt | $106.23K | $121.13K | $135.69K | $149.91K | $163.71K | — | -12.3% |
| Total liabilities | $335.76K | $799.85K | $914.50K | $553.65K | $587.39K | — | -58.0% |
| Retained earnings | -$5.77M | -$5.59M | -$5.22M | -$6.27M | -$5.95M | — | -3.2% |
| Shareholder equity | $17.42M | $16.72M | $15.88M | $14.77M | $14.27M | — | +4.2% |
| Working capital | $3.85M | $2.90M | $2.77M | $1.04M | $2.67M | — | +32.7% |
| Net tangible assets | $17.42M | $16.72M | $15.88M | $14.77M | $14.27M | — | +4.2% |
| Shares issued | 144.13M | 141.28M | 139.86M | 139.71M | 139.46M | — | +2.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$179.49K | -$373.27K | $1.05M | -$316.92K | -$270.12K | +51.9% |
| Depreciation & amortisation | $20.05K | $20.24K | $22.60K | $22.60K | $22.32K | -1.0% |
| Stock-based compensation | $47.96K | $15.57K | $342.84K | $7.69K | $7.22K | +208.1% |
| Change in working capital | -$325.12K | -$469.16K | $380.08K | -$98.35K | $37.14K | +30.7% |
| Operating cash flow | -$455.80K | -$418.27K | $261.39K | -$169.80K | -$322.57K | -9.0% |
| Capital expenditure | -$138.24K | -$329.70K | -$270.31K | -$1.19M | -$783.61K | +58.1% |
| Investing cash flow | -$138.24K | -$329.70K | -$270.31K | -$1.19M | -$783.61K | +58.1% |
| Financing cash flow | $363.18K | $172.07K | -$14.77K | -$14.49K | $3.17M | +111.1% |
| Free cash flow | -$594.05K | -$747.96K | -$8.91K | -$1.36M | -$1.11M | +20.6% |
| End cash position | $500.52K | $752.22K | $1.21M | $1.25M | $2.59M | -33.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders3.81%
Held by institutions8.25%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.15
+2.88% from price
SMA 20
0.13
+13.38% from price
SMA 50
0.11
+33.48% from price
SMA 100
0.11
+34.80% from price
SMA 200
0.13
+18.70% from price
EMA 12
0.14
+5.59% from price
EMA 26
0.13
+15.26% from price
EMA 50
0.12
+24.34% from price
RSI (14)
67.7
Neutral
MACD (12,26,9)
0.01
Hist 0.00
ATR (14)
0.01
3.33% of price
Realised vol 30D
138.6%
Annualised
Bollinger upper
0.17
20, 2σ
Bollinger lower
0.10
20, 2σ
50 / 200 cross
Death
0.11 vs 0.13
Trend bias
Above 200
+18.70%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.92
More volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
138.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-56.4%
Peak to trough
Max drawdown 5Y
-89.4%
Peak to trough
ATR 14
0.01
3.33% of price
Beta (reported)
0.99
5Y monthly, from filing
Headlines
New Zealand moves to ban social media for under-16s
AFP · 4m ago
Chorus Ltd (CHRYY) (FY 2026) Earnings Call Highlights: Fiber Growth and Strategic Expansion ...
GuruFocus.com · 5m ago
Property For Industry Ltd (NZSE:PFI) (FY 2026) Earnings Call Highlights: Double-Digit FFO ...
GuruFocus.com · 5m ago
Start of Day Message
Business Wire · 5m ago
Fastly's CFO Sells Over 148,000 Shares Worth $4.2 Million. Here's What That Means for Investors.
Motley Fool · 19m ago
Shein Targets $27 Billion Valuation in Long-Awaited Hong Kong IPO
The Wall Street Journal · 24m ago
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
PR Newswire · 25m ago
Over 100 expats trek across 10 districts to uncover the real Shenzhen
GlobeNewswire · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.